466 filings
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
4
Young Jonathan
3 Apr 24
Akero Therapeutics / Jonathan Young ownership change
6:55pm
144
Young Jonathan
1 Apr 24
Notice of proposed sale of securities
4:17pm
8-K
AKRO
Akero Therapeutics Inc
18 Mar 24
Unregistered Sales of Equity Securities
4:31pm
4
Catriona Yale
15 Mar 24
Akero Therapeutics / Catriona Yale ownership change
4:45pm
4
qz8voowh0acsocgns3j
15 Mar 24
Akero Therapeutics / William Richard White ownership change
4:44pm
4
s032gi 17h
15 Mar 24
Akero Therapeutics / Andrew Cheng ownership change
4:43pm
4
79757u0dmfz
15 Mar 24
Akero Therapeutics / Jonathan Young ownership change
4:42pm
4
ymy1fhkcpiy
15 Mar 24
Akero Therapeutics / Timothy Rolph ownership change
4:42pm
SC 13G
8lmu5ue7skwayv
15 Mar 24
Akero Therapeutics / GENERAL ATLANTIC ownership change
10:08am
4
x6um9h9hh
6 Mar 24
Akero Therapeutics / Andrew Cheng ownership change
8:14pm
4
566 5xnju56
6 Mar 24
Akero Therapeutics / Catriona Yale ownership change
8:13pm
8-K
prrc16
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
424B5
17wkew4w25wf4 kyiw
6 Mar 24
Prospectus supplement for primary offering
5:16pm
4
kyqh k0ym
5 Mar 24
Akero Therapeutics / Jonathan Young ownership change
5:16pm
144
i06ha
4 Mar 24
Notice of proposed sale of securities
5:34pm
144
2tst6db a3
4 Mar 24
Notice of proposed sale of securities
5:30pm
424B5
are120qzn5
4 Mar 24
Prospectus supplement for primary offering
5:21pm
8-K
brdhi 9dffk362
4 Mar 24
Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study
7:55am
S-8
g7pphlr6asxw mu5
29 Feb 24
Registration of securities for employees
4:42pm